News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VaxInnate Corporation’s License Agreement With Emergent BioSolutions (EBS) Improves U.S. Preparedness for Potential Flu Pandemics


1/16/2013 9:32:44 AM

CRANBURY, N.J.--(BUSINESS WIRE)--A license agreement for the manufacture and sale of VaxInnate Corporation’s recombinant flu vaccine by Emergent BioSolutions is a step toward helping the United States be better prepared in the event of an influenza pandemic. VaxInnate is a biotechnology firm pioneering breakthrough technology for the development of novel vaccines.

Read at BioSpace.com


comments powered by Disqus
   
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES